Metabolic syndrome prevalence is high in the U.S.
the ONA take:
Researchers have found a high prevalence of metabolic syndrome in the US population. Estimates are nearly 35% of all US adults and 50% of those 60 years and older in 2011-2012 have the condition.
Metabolic syndrome is a combination of health conditions, including obesity, high blood pressure, elevated blood sugar, and poor lipid profile that contribute to cardiovascular illness and death.
Researchers used National Health and Nutrition Examination Survey (NHANES) 2003-2012 data to evaluate trends in metabolic syndrome among adults age 20 years and older. Prevalence was higher in women compared with men.
When stratified by race/ethnicity, the highest prevalence was in Hispanics, followed by non-Hispanic whites and blacks. Overall prevalence increased from 32.9% in 2003-2004 to 34.7% in 2011-2012.
By age groups, prevalence of metabolic syndrome increased by age groups. Among people age 20 to 39 years, prevalence was 18.3%, and it increased to 46.7% among those 60 years or older. The researchers defined this as “a concerning observation given the aging US population.”
Greater awareness of the condition and its health consequences may be contributing to improved treatment of risk factors. Finally, recent NHANES data demonstrate that obesity rates are stabilizing, which may lead to stabilizing the prevalence of metabolic syndrome as well.
Researchers have found a high prevalence of metabolic syndrome in the US population.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|